Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

Investing.com - With more than two-thirds of the benchmark S&P 500 having reported their latest quarterly results, the number ...

Biotech stocks are showing signs of life after years of pressure from rate-driven factors, with several names posting ...